Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.53 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9359831 | 0.85 | KDM4E (0.61) | TAS1R3TAS1R1ALDH1A1LMNAHPGD | |
| SCHEMBL19832508 | 0.85 | POLB (0.51) | TAS1R3TAS1R1ALDH1A1LMNAHPGD | |
| SCHEMBL4349764 | 0.83 | THRB (0.55) | ALDH1A1LMNATHRBKDM4EMAPT | |
| SCHEMBL13197622 | 0.83 | TAS1R3 (0.59) | TAS1R3TAS1R1ALDH1A1LMNAHPGD | |
| SCHEMBL5818147 | 0.83 | HPGD (0.65) | TAS1R3TAS1R1ALDH1A1LMNAHPGD | |
| SCHEMBL26417166 | 0.83 | MAPK1 (0.56) | TAS1R3TAS1R1ALDH1A1RAB9AHDAC2 | |
| SCHEMBL26417189 | 0.81 | EPHX2 (0.59) | TAS1R3TAS1R1SMN1; SMN2MAPTRAB9A | |
| SCHEMBL8744962 | 0.81 | MAPK1 (0.59) | TAS1R3TAS1R1ALDH1A1RAB9AHDAC2 | |
| SCHEMBL20966259 | 0.80 | CYP1A2 (0.62) | TAS1R3TAS1R1ALDH1A1LMNAHPGD | |
| SCHEMBL27353786 | 0.80 | TAS1R3 (0.60) | TAS1R3TAS1R1ALDH1A1LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 399 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7740832-B1 | Cosmetic composition comprising at least a tacky polymer and at least a fixing polymer | L'OREAL S.A. (FR) | 2010-06-22 | — | — | US | claimed |
| EP-1083866-B1 | COSMETIC COMPOSITION COMPRISING AT LEAST AN ACRYLIC OR METHACRYLIC ESTER TACKY POLYMER | OREAL (FR) | 2004-10-27 | — | — | EP | claimed |
| EP-0875541-B1 | Single phase system based on coreactive latex resins | ATOFINA (FR) | 2003-09-10 | — | — | EP | claimed |
| EP-0875543-B1 | Single phase systeme based on coreactive copolymers | ATOFINA (FR) | 2003-07-02 | — | — | EP | claimed |
| US-20020132129-A1 | WATER-RESISTANT ADHESIVE BASED ON A VINYL ACETATE EMULSION POLYMER CONTAINING A NONIONIC POLYMURETHANE | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2002-09-19 | — | — | US | claimed |
| EP-1083866-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST AN ACRYLIC OR METHACRYLIC ESTER TACKY POLYMER | L'OREAL (FR) | 2001-03-21 | — | — | EP | claimed |
| US-6133365-A | THE TWO LATEXES WHICH MAKE UP THE MIXTURE OF CROSSLINKABLE MONOMERS ARE FUNCTIONALIZED, ONE BY A GROUP OF THE UREIDO TYPE AND THE OTHER BY A GROUP OF N-ALKYLOL TYPE AND CAN BE MIXED WITHOUT REACTION DURING STORAGE | ATOFINA (FR) | 2000-10-17 | — | — | US | claimed |
| WO-1999063954-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST AN ACRYLIC OR METHACRYLIC ESTER TACKY POLYMER | L'OREAL (FR) | 1999-12-16 | — | — | WO | claimed |
| EP-0875541-A1 | Single phase system based on coreactive latex resins | ELF ATOCHEM S.A. (FR) | 1998-11-04 | — | — | EP | claimed |
| EP-0875543-A1 | Single phase systeme based on coreactive copolymers | ELF ATOCHEM S.A. (FR) | 1998-11-04 | — | — | EP | claimed |
| US-20260117114-A1 | Method of Improving Performance of Relative Permeability Modifiers | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12589607-B2 | Printing processes for producing textured images | NUR INK INNOVATIONS LTD (IL) | 2026-03-31 | — | — | US | disclosed |
| US-12576103-B2 | Heparin and N-acetylcysteine for the treatment of lung injury | ATOSSA THERAPEUTICS, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| WO-2026043945-A1 | CERAMIC COATED SEPARATOR AND ADHESIVE | THE LUBRIZOL CORPORATION (US) | 2026-02-26 | — | — | WO | disclosed |
| US-20260034166-A1 | HEPARIN COMPOSITIONS FOR TREATMENT OF LUNG DAMAGE AND METHODS OF USE THEREOF | ATOSSA THERAPEUTICS, INC. | 2026-02-05 | — | — | US | disclosed |
| US-4021397-A | LATEX, HYDROXYLAMINE SULFATE | THE B. F. GOODRICH COMPANY (US) | 1977-05-03 | — | — | US | disclosed |
| US-4007147-A | Water based hardboard coating compositions of an acrylic ester interpolymer latex, a vinyl chloride polymer latex, a water reducible thermoset resin, and pigment(s) | THE B. F. GOODRICH COMPANY (US) | 1977-02-08 | — | — | US | disclosed |
| US-4002801-A | POLYVINYL CHLORIDE CORE | THE B. F. GOODRICH COMPANY (US) | 1977-01-11 | — | — | US | disclosed |
| US-3996177-A | AMINO RESINS, WATER AND CHEMICAL RESISTANCE | THE B. F. GOODRICH COMPANY (US) | 1976-12-07 | — | — | US | disclosed |
| US-3948870-A | Method of preparing hydrophilic copolymers of acrylonitrile | CESKOSLOVENSKA AKADEMIE VED (CS) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589607-B2 | Printing processes for producing textured images | VCL, INPP5D, KDM4E | TAS1R3 1979/4885TAS1R1 2052/4885ALDH1A1 3074/4885 |
| US-20260117114-A1 | Method of Improving Performance of Relative Permeability Modifiers | MYH10, MYH14, NIM1K | TAS1R3 3603/4885TAS1R1 3171/4885ALDH1A1 4375/4885 |
| US-12576103-B2 | Heparin and N-acetylcysteine for the treatment of lung injury | SERPINC1, TXNRD2, TXN | TAS1R3 1454/4885TAS1R1 1241/4885ALDH1A1 3305/4885 |
| US-20260034166-A1 | HEPARIN COMPOSITIONS FOR TREATMENT OF LUNG DAMAGE AND METHODS OF USE THEREOF | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDAC6, MUC1 | TAS1R3 3357/4885TAS1R1 3548/4885ALDH1A1 2080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.